Company ImmuCell Corporation

Equities

ICCC

US4525253062

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
5.3 USD +0.19% Intraday chart for ImmuCell Corporation +4.13% +4.13%

Business Summary

ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line, providing Immediate Immunity for the prevention of scours in newborn dairy and beef calves. It expanded this line into four different products with formulations targeting E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. This product line provides Immediate Immunity to newborn calves. The Company is engaged in the development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. The Company's products reduce the use of traditional antibiotics in food producing animals.

Sales per Business

USD in Million2021Weight2022Weight Delta
Scours
99.2 %
19 98.4 % 18 99.2 % -2.75%
Mastitis
0.8 %
0 0.0 % 0 0.8 % -
Other
0.0 %
0 1.6 % 0 0.0 % -99.53%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
91.7 %
17 86.4 % 17 91.7 % +2.41%
Other
8.3 %
3 13.6 % 2 8.3 % -41.01%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 89-08-31
Director/Board Member 48 09-12-31
Corporate Officer/Principal 68 16-04-04

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 63 89-08-31
Chairman 67 06-12-20
Director/Board Member 48 09-12-31
Director/Board Member 59 14-03-30
Director/Board Member 58 18-01-29
Director/Board Member 64 20-06-09
Director/Board Member - 23-06-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,818,165 5,561,148 ( 71.13 %) 67,301 ( 0.8608 %) 71.13 %

Shareholders

NameEquities%Valuation
644,019 8.309 % 3 M $
514,003 6.632 % 3 M $
401,819 5.184 % 2 M $
215,752 2.784 % 1 M $
Vanguard Group, Inc. (Subfiler)
2.666 %
206,606 2.666 % 1 M $
142,845 1.843 % 754 222 $
136,882 1.766 % 722 737 $
Renaissance Technologies LLC
1.628 %
126,189 1.628 % 666 278 $
Cresset Asset Management LLC
1.337 %
103,606 1.337 % 547 040 $
103,606 1.337 % 547 040 $

Company contact information

ImmuCell Corp.

56 Evergreen Drive

04103, Portland

+207 878 2770

http://www.immucell.com
address ImmuCell Corporation(ICCC)